Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keating Securities was a boutique investment bank and broker-dealer that specialized in providing capital and advisory services to emerging growth companies, with a particular focus on the life sciences and technology sectors. The firm was known for its expertise in pre-IPO financing and the development of Special Purpose Acquisition Companies (SPACs). It operated in conjunction with Keating Capital, a publicly traded business development company, to support private companies in their transition to the public markets. Led by Timothy Keating, the firm facilitated numerous transactions for healthcare-related entities before its registration was terminated. Today, the legacy of the firm is primarily associated with its early advocacy for the SPAC asset class and pre-IPO investment strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keating Securities.